Emily Bellile

2 articles listing Emily Bellile in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial Nature Communications
2. BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity Nature Communications